TCR-JANUS 衔接蛋白实现双特异性靶向以克服 TCR-T 细胞治疗中的肿瘤异质性
TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy.
基于 T 细胞受体(TCR)的免疫疗法受限于肿瘤抗原异质性,后者常导致复发。
英文原题:Characterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.
我们的研究结果提供了对 HPV6/11 感染的局部免疫反应的见解,并为开发针对 JORRP 的更有效的免疫治疗策略提供了信息。
青少年发病的复发性呼吸道乳头状瘤病 (JORRP) 是由低危人乳头瘤病毒 (HPV) 6 型和 11 型上皮细胞持续感染引起的。虽然据报道多种浸润的免疫细胞可介导疾病进展,但对乳头状瘤中 HPV 反应性 T 细胞亚群的了解仍然难以捉摸。通过单细胞RNA测序和RNA微阵列,我们发现具有强干扰素γ(IFN-)产生能力的CD8+组织驻留记忆T(CD8+ T RM)细胞扩增,并且与手术频率中的疾病严重程度呈负相关。这些 IFN-+ CD8+ 记忆 T 细胞很容易在体外被负载 HPV11 E7 肽池的自体树突状细胞激活和扩增。此外,在 JORRP 乳头状瘤组织中观察到 T 细胞受体 (TCR) 克隆扩增,表明 TCR 库偏向 HPV 特异性识别。最后,我们从 IFN-+ CD8+ 记忆 T 细胞中鉴定并表征了 HPV11 E7 特异性候选 TCR 克隆型,表明它们在 TCR 工程 T 细胞 (TCR-T) 治疗 HPV11 相关疾病中的潜在应用。我们的研究结果提供了对 HPV6/11 感染的特异性局部免疫反应的见解,并强调了 IFN- + CD8+ T RM 细胞在抗 HPV6/11 T 细胞免疫中的重要性。 重要性 乳头状瘤中人乳头瘤病毒 (HPV) 6/11 感染的持续复发强调了青少年发病的复发性呼吸道乳头状瘤病 (JORRP) 患者局部免疫反应的失败。我们之前的研究表明,T 细胞构成了 JORRP 乳头状瘤组织中的主要免疫细胞群。了解 JORRP 乳头状瘤组织内 T 细胞介导的免疫反应对于疾病控制至关重要。在本研究中,我们将 CD8+ 组织驻留记忆 T (CD8+ T RM ) 细胞描述为负责局部抗 HPV6/11 免疫的主要 T 细胞亚群。此外,我们从 IFN-+ CD8+ 记忆 T 细胞中鉴定出两种 HPV11 E7 特异性候选 T 细胞受体 (TCR) 克隆型。总体而言,我们的研究结果提供了对 HPV6/11 感染的局部免疫反应的见解,并为开发针对 JORRP 的更有效的免疫治疗策略提供了信息。
Juvenile-onset recurrent respiratory papillomatosis (JORRP) is caused by persistent infection of epithelial cells by low-risk human papillomavirus (HPV) types 6 and 11. While multiple infiltrated immune cells have been reported to mediate disease progress, knowledge of HPV-reactive T-cell subsets in papillomas remains elusive. Through single-cell RNA sequencing and RNA microarray, we found that CD8+ tissue-resident memory T (CD8+ T RM ) cells with strong interferon-gamma (IFN- ) production expanded, and were negatively correlated to the disease severity in the frequency of surgery. These IFN- + CD8+ memory T cells were readily activated and expanded in vitro by autologous dendritic cells loaded with HPV11 E7 peptide pool. Moreover, T cell receptor (TCR) clonal expansion was observed in JORRP papilloma tissues, indicating a biased TCR repertoire toward HPV-specific recognition. Finally, we identified and characterized HPV11 E7-specific candidate TCR clonotypes from IFN- + CD8+ memory T cells, suggesting their potential application in TCR-engineered T cells (TCR-T) therapy for HPV11-related diseases. Our findings provided insights into the specific local immune response to HPV6/11 infection and highlighted the importance of IFN- + CD8+ T RM cells in anti-HPV6/11 T-cell immunity.IMPORTANCEThe persistent recurrence of human papillomavirus (HPV) 6/11 infection in papillomas underscores the failure of local immune responses in patients with juvenile-onset recurrent respiratory papillomatosis (JORRP). Our previous study demonstrated that T cells constitute the predominant immune cell population in JORRP papilloma tissues. Understanding the T-cell-mediated immune responses within JORRP papilloma tissues is crucial for disease control. In the present study, we characterized CD8+ tissue-resident memory T (CD8+ T RM ) cells as the primary T-cell subset responsible for local anti-HPV6/11 immunity. Moreover, we identified two HPV11 E7-specific candidate T cell receptor (TCR) clonotypes out of IFN- + CD8+ memory T cells. Overall, our findings provided insights into the local immune responses to HPV6/11 infection and offered information for developing more effective immunotherapeutic strategies against JORRP.
MEMBER ACCOUNT
登录成功会直接打开下一页。